Does chloroquine decrease liver enzyme abnormalities induced by methoterexate in patients with rheumatoid arthritis?

Journal of Research in Medical Sciences

Volumn 10, Issue 3, 2005, Pages 135-138

  Mottaghi, Peyman ^a   Karimzade, H ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chloroquine; Liver enzyme; Methotrexate; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; LIVER ENZYME; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24644436897     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Harris ED. Treatment of rheumatoid arthritis. In: Ruddy S, Sledge CB, editors. Kelley's Textbook of rheumatology. 6th ed. Philadelphia: W.B. Saunders 2001:1001-19
2. Weinblatt M. Methotrexatet. In: Ruddy S, Sledge CB, editors. Kelley's Textbook of rheumatology. 6th ed. Philadelphia: W.B. Saunders 2001:1015-6
3. Tugwell P, Bennett K. Weinblatt M. Methotrexate in rheumatoid arthritis. Ann Int Med 1987;107:418-9
4. Bellamy N, Mayer A. Current practice in antimalarial drug prescribing in rheumatoid arthritis. J Rheumatol 1986;13: 551-6
5. Fries JF, Singh G, Edward D. Aspirin, Hydroxychloroquine and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33(11):1611-9
6. Felson DT, Anderson J, Armour WJ. Use of short term efficacy/ toxicity trade offs to select second-line drugs in rheumatoid arthritis, a Meta analysis of published trials. Arthritis Rheum 1992;35(10):1117-23
7. Drosos AA, Psychos D, Andonopoulos AP. Methotrexate therapy in rheumatoid arthritis (a two years prospective follow up). Clin Rheumatol 1990;9(3):333-41
8. Weinblott ME, Maier AL, Pina I, Krevsky B. Long term experience with low dose weekly methotrexate in rheumatoid arthritis. J Rheumatol 1990;22:33-7
9. Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis. Arthritis Rheum 1986;29:822-7
10. Elkayam O, Yaron M, Zhukovsky G, Segal R Capsi D. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients. Rheumatology international .1997:17(2):49-53
11. Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA. Methotrexate, hyroxychloroquine, and intramuscular gold in rheumatoid arthritis. J Rheumatol 2003;30(8):1981-2
12. Carmichael SJ, Beal J, Day RO, Tett SE. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increase exposure to methotrexate. J Rheumatol 2002;29(10):2031-3
13. Carmichael SJ, Charles B, Tett SE. Population pharmacokinetics of hydroxylchloroquine in patients with rheumatoid arthritis. Ther Drug Monit 2003;25(6):671-81
14. Van jaaresveld CH, Jahngier ZN, Jacobs JW, Blaauw AA, Van Albada - kuipers GA. Toxicity of antirheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Rheumatology (Oxford) 2000;39(12):1374-82